William W Chu
Affiliation: University of Wisconsin
- Metastatic intracardiac tumour from liposarcomaWilliam W Chu
Department of Medicine, Cardiovascular Section, University of Wisconsin Hospital and Clinics, Madison 53792, USA
Can J Cardiol 18:777-8. 2002
- SPECT imaging of apical hypertrophic cardiomyopathyWilliam W Chu
Department of Cardiology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792 3248, USA
Clin Nucl Med 27:785-7. 2002..A case showing the typical scintigraphic and cardiac echocardiographic findings of apical hypertrophic cardiomyopathy is presented...
- Use of a percutaneous vascular suture device for closure of an inadvertent subclavian artery punctureMichael C Fraizer
Section of Cardiovascular Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA
Catheter Cardiovasc Interv 59:369-71. 2003..We report a case of inadvertent subclavian arterial sheath placement during an attempted internal jugular venous catheterization. This was successfully removed using a percutaneous vascular suture device...
- Evolving clinical applications of cardiac markers: a review of the literatureWilliam W Chu
Section of Cardiovascular Medicine, Department of Medicine, University of Wisconsin Hospital and Clinics, USA
WMJ 101:49-55. 2002....
- Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stentsPramod K Kuchulakanti
Division of Cardiology, Department of Medicine, Washington Hospital Center, Washington, DC 20010, USA
Circulation 113:1108-13. 2006..Careful management is warranted in patients with renal failure and in those undergoing treatment for in-stent restenosis and bifurcations. Special focus on clopidogrel compliance may minimize the incidence of ST after DES implantation...
- Increased late sodium current in myocytes from a canine heart failure model and from failing human heartCarmen R Valdivia
Departments of Medicine, Surgery and Physiology, University of Wisconsin Hospital and Clinics, University of Wisconsin, 600 Highland Avenue H6/349, Madison, WI 53792, USA
J Mol Cell Cardiol 38:475-83. 2005..We conclude that a peak I(Na) is decreased, and non-inactivating late I(Na) is increased in heart failure and this may contribute to action potential prolongation and the generation of arrhythmia...
- Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysisSang-Wook Kim
Cardiovascular Research Institute/Medstar Research Institute, Washington Hospital Center, Washington, DC, USA
Am J Cardiol 98:1206-11. 2006..However, sequential intravascular ultrasound imaging showed that the frequency and amount of plaque prolapse were neither increased nor decreased by additional higher pressure inflations...
- Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft interventionWilliam W Chu
Washington Hospital Center, Washington, DC, USA
Am J Cardiol 97:34-7. 2006..84). In conclusion, the use of SESs in patients who undergo SVG intervention with a distal protection device is clinically safe and feasible but is not associated with decreased clinical events up to 1 year compared with BMSs...
- Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patientsLeonardo C Clavijo
The Division of Cardiology, Washington Hospital Center, Washington, DC, USA
Am J Cardiol 97:981-3. 2006..4%) in the group treated with 5% dextrose. The relative risk decrease was 73% (p = 0.03). This is an effective, quick, and inexpensive method of improving outcomes in patients who undergo percutaneous coronary interventions...
- Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft interventionWilliam W Chu
Division of Cardiology, Washington Hospital Center, Washington, DC 20010, USA
J Interv Cardiol 19:121-5. 2006..75). CONCLUSIONS: The use of DES in patients undergoing SVG intervention with a DPD is clinically safe and feasible. As compared to SES, PES have the same efficacy and clinical outcomes in SVG interventions up to 6 months...
- Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patientsSalah-Eddine Hassani
Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, Washington, DC, USA
J Invasive Cardiol 18:273-7. 2006..There was, however, a higher incidence of mortality in dialysis patients at 6 months, mostly influenced by contributing comorbidities and more severe conditions at presentation...
- Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary interventionSundeep Mishra
Division of Cardiology, Washington Hospital Center, Washington, DC, USA
Am J Cardiol 98:608-12. 2006..Therefore, in high-risk patients undergoing PCI, liberal use of a P-IABP should be considered...